NVST Envista Holdings Corp
Dental Equipment & Supplies · NYSE · SEC CIK 1757073 · Fiscal year ends 12/31
Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.8%
TTM net income YoY4,041.2%
TTM EPS YoY4,177.8%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR49.2%
Margins
Gross margin55.9%
Operating margin25.4%
Net margin22.0%
FCF margin8.4%
EBITDA margin29.3%
Returns
ROE20.5%
ROA11.3%
ROIC (approx.)20.0%
Asset turnover0.51x
Leverage & solvency
Liabilities / assets45.0%
Debt / equity0.46x
Current ratio2.45x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio5.9%
Payout ratio—
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-10-02 | 2026Q22026-07-03 | 2026Q12026-04-03 | 2025Q4*2025-12-31 | 2025Q32025-09-26 | 2025Q22025-06-27 | 2025Q12025-03-28 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $691.50M | $730.50M | $705.50M | $750.60M | $669.90M | $682.10M | $616.90M | $652.90M |
| Cost of revenue | $290.90M | $323.50M | $315.40M | $340.00M | $299.70M | $312.20M | $280.90M | $280.40M |
| Gross profit | $400.60M | $407.00M | $390.10M | $410.60M | $370.20M | $369.90M | $336.00M | $372.50M |
| R&D expense | $29.30M | $30.40M | $30.00M | $32.10M | $28.30M | $28.30M | $25.30M | $26.70M |
| SG&A expense | $284.20M | $296.30M | $297.60M | $305.20M | $284.40M | $295.30M | $271.70M | $299.70M |
| Operating income | $515.20M | $80.30M | $62.50M | $73.30M | $57.50M | $46.30M | $39.00M | $46.10M |
| Pretax income | $500.20M | $74.40M | $52.20M | $57.60M | $49.90M | $40.70M | $29.00M | $36.50M |
| Income tax | -$8.10M | $20.70M | $13.50M | $24.70M | $80.20M | $14.30M | $11.00M | $35.30M |
| Net income | $508.30M | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M | $18.00M | $1.20M |
| EBITDA | $540.60M | $108.10M | $91.70M | $102.40M | $86.70M | $76.10M | $66.90M | $73.90M |
| EPS (basic) | 3.16 | 0.33 | 0.24 | — | -0.18 | 0.16 | 0.10 | — |
| EPS (diluted) | 3.11 | 0.33 | 0.23 | — | -0.18 | 0.16 | 0.10 | — |
| Weighted avg. shares (diluted) | 163.40M | 164.10M | 166.40M | — | 166.10M | 169.90M | 173.60M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.16B | $1.13B | $1.08B | $1.21B | $1.13B | $1.11B | $1.08B | $1.07B |
| Receivables | $448.50M | $436.90M | $436.60M | $429.60M | $405.90M | $422.80M | $393.10M | $363.00M |
| Inventory | $285.20M | $290.90M | $300.30M | $288.10M | $290.80M | $281.90M | $261.30M | $241.00M |
| Current assets | $2.00B | $1.96B | $1.92B | $2.03B | $1.95B | $1.93B | $1.85B | $1.79B |
| PP&E, net | $300.70M | $295.70M | $298.70M | $296.80M | $288.40M | $287.00M | $279.70M | $277.00M |
| Goodwill | $2.34B | $2.35B | $2.36B | $2.36B | $2.36B | $2.37B | $2.30B | $2.26B |
| Intangibles | $593.30M | $613.30M | $633.00M | $627.20M | $645.80M | $666.10M | $650.20M | $649.90M |
| Total assets | $5.61B | $5.60B | $5.58B | $5.68B | $5.64B | $5.66B | $5.47B | $5.35B |
| Current liabilities | $816.30M | $807.30M | $786.60M | $852.60M | $821.70M | $793.90M | $873.30M | $878.70M |
| Short-term debt | — | — | — | $0 | $0 | $0 | $116.20M | $116.00M |
| Long-term debt | $1.43B | $1.44B | $1.44B | $1.45B | $1.45B | $1.45B | $1.30B | $1.28B |
| Total debt | $1.43B | $1.44B | $1.44B | $1.45B | $1.45B | $1.45B | $1.41B | $1.39B |
| Total liabilities | $2.52B | $2.52B | $2.50B | $2.57B | $2.55B | $2.53B | $2.43B | $2.42B |
| Shareholders' equity | $3.09B | $3.08B | $3.08B | $3.11B | $3.09B | $3.14B | $3.04B | $2.93B |
| Net debt | $270.20M | $310.70M | $356.30M | $236.60M | $311.50M | $334.50M | $334.70M | $325.20M |
| Shares outstanding | 160.30M | 160.60M | 162.90M | 163.80M | 165.00M | 166.80M | 171.50M | 172.20M |
| Cash flow statement | ||||||||
| Operating cash flow | $77.90M | $119.20M | -$3.30M | $108.00M | $78.70M | $88.70M | $300,000 | $132.40M |
| Capital expenditure | $16.10M | $14.90M | $12.50M | $16.30M | $10.80M | $12.30M | $5.90M | $8.60M |
| Free cash flow | $61.80M | $104.30M | -$15.80M | $91.70M | $67.90M | $76.40M | -$5.60M | $123.80M |
| Investing cash flow | -$13.10M | -$14.30M | -$68.90M | -$15.50M | -$9.70M | -$17.10M | -$8.80M | -$7.40M |
| Financing cash flow | -$9.60M | -$60.70M | -$45.60M | -$25.20M | -$41.70M | -$86.40M | -$17.60M | -$900,000 |
| Depreciation & amortization | $25.40M | $27.80M | $29.20M | $29.10M | $29.20M | $29.80M | $27.90M | $27.80M |
| Stock-based compensation | $9.80M | $9.50M | $10.20M | $10.40M | $10.40M | $9.70M | $7.10M | $9.20M |
Free plan shows the latest 8 periods; Pro shows all 35 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.